A Randomized Trial of Paracentesis plus Intraperitoneal Tumor Necrosis Factor- versus Paracentesis Alone in Patients with Symptomatic Ascites from Recurrent Ovarian Carcinoma

By Hirte H.W.   Miller D.   Tonkin K.   Findlay B.   Capstick V.   Murphy J.   Buckman R.   Carmichael J.   Levine M.   Hill W.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 80-87

Elsevier

Access to resources Recommend Favorite

Evaluation of low-dose intraperitoneal interferon- for palliation of ascites in patients with non-ovarian gynecologic malignancies

By Khabele D.   Runowicz C.D.   Fields A.L.   Anderson P.S.   Goldberg G.L.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 420-423

Elsevier

Access to resources Recommend Favorite

The Ability of Existing Questionnaires to Measure Symptom Change After Paracentesis for Symptomatic Ascites

By Easson Alexandra   Bezjak Andrea   Ross Susan   Wright Jim  

Annals of Surgical Oncology, Vol. 14, Iss. 8, 2007-08 ,pp. : 2348-2357

Springer Publishing Company

Access to resources Recommend Favorite

A pilot study of combination intraperitoneal recombinant human endostatin and chemotherapy for refractory malignant ascites secondary to ovarian cancer

By Zhao Jing   Chen Xinxiao   Zhang Aimu   Xu Feng   Hu Meilong   Xie Congying   Xue Shengliu  

Medical Oncology, Vol. 31, Iss. 4, 2014-04 ,pp. : 1-7

Humana Press, Inc

Access to resources Recommend Favorite

Intraperitoneal chemotherapy for the treatment of ovarian cancer

By Dorff Tanya  

The Women's Oncology Review, Vol. 5, Iss. 4, 2005-12 ,pp. : 203-211

Informa Healthcare

Access to resources Recommend Favorite